Definitive Chemoradiation for Oesophageal Cancer - a Standard of Care in Patients with Non-metastatic Oesophageal Cancer

We present data showing that dCRT is well tolerated and should be considered as an alternative to surgery for all patients with locally advanced oesophageal cancer, not only those with co-morbidity. Furthermore, the benefits of dCRT are not confined to carcinomas with squamous histology.